SCHEMBL13655992

SCHEMBL13655992

B=C1Nc2ccccc2CCN1C1CCNCC1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR2C P28335 12/20 0.48
HTR2B P41595 8/20 0.48
HTR2A P28223 6/20 0.44
NPC1 O15118 1/20 0.36
MAPK13 O15264 1/20 0.36
MAPK12 P53778 1/20 0.36
MAPK11 Q15759 1/20 0.36
MAPK14 Q16539 1/20 0.36
NOS1 P29475 3/20 0.35
NOS2 P35228 3/20 0.35
NOS3 P29474 1/20 0.35
CHRM2 P08172 1/20 0.35
ADRA2A P08913 1/20 0.35
CYP2D6 P10635 1/20 0.35
CHRM1 P11229 1/20 0.35
ADRA2B P18089 1/20 0.35
ADRA2C P18825 1/20 0.35
CHRM3 P20309 1/20 0.35
ADRA1D P25100 1/20 0.35
HTR1B P28222 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL651023 0.84 HTR2C (0.49) HTR2CHTR2BHTR2ANPC1MAPK13
SCHEMBL30178303 0.84 HTR2C (0.49) HTR2CHTR2BHTR2ANPC1MAPK13
Hydrochloric Acid SCHEMBL1819629 0.83 HTR2C (0.48) HTR2CHTR2BHTR2ANPC1MAPK13
SCHEMBL12372576 0.83 HTR2C (0.48) HTR2CHTR2BHTR2ANPC1MAPK13
SCHEMBL2709111 0.75 HTR2C (0.77) HTR2CHTR2BHTR2ANOS1NOS2
Trifluoroacetic Acid SCHEMBL4781145 0.75 CALCRL (0.46) HTR2CHTR2BRAMP1CALCRL
Hydrochloric Acid SCHEMBL3947175 0.74 HTR2C (0.75) HTR2CHTR2BHTR2ANOS1NOS2
SCHEMBL723359 0.74 HTR2C (0.61) HTR2CHTR2BHTR2APARP1
SCHEMBL30015409 0.74 HTR2C (0.61) HTR2CHTR2BHTR2APARP1
Hydrochloric Acid SCHEMBL11737591 0.72 HTR2C (0.59) HTR2CHTR2BHTR2APARP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2108648-A1 Selected CGRP antagonists, method for their manufacture and use as medicines Boehringer Ingelheim International GmbH (DE) 2009-10-14 EP disclosed